Analysis of Efficiency Improvement Path Scheme in Biomedical Industry Driven by AI

Dajiang Guo

European Journal of AI, Computing & Informatics, 2025, vol. 1, issue 3, 10-18

Abstract: The biomedical industry faces persistent efficiency challenges, including prolonged R&D cycles, high development costs, complex clinical trials, and fragmented data management. Driven by advances in artificial intelligence (AI), novel solutions are emerging to address these bottlenecks across the drug discovery, clinical, manufacturing, and knowledge management domains. This review systematically analyzes AI-driven efficiency improvement pathways, highlighting accelerated drug discovery, optimized clinical trials, intelligent manufacturing and supply chain, and data-driven decision support. Key challenges, such as data quality, regulatory constraints, system integration, and talent gaps, are discussed, alongside potential future developments in self-supervised learning and generative models. The study emphasizes the transformative potential of AI to enhance productivity, reduce costs, and support informed decision-making, offering strategic insights for enterprises seeking sustainable innovation in the biomedical sector.

Keywords: artificial intelligence; biomedical industry; drug discovery; clinical trials; efficiency improvement (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://pinnaclepubs.com/index.php/EJACI/article/view/311/318 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dba:ejacia:v:1:y:2025:i:3:p:10-18

Access Statistics for this article

More articles in European Journal of AI, Computing & Informatics from Pinnacle Academic Press
Bibliographic data for series maintained by Joseph Clark ().